Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa
Purpose: Globotriaosylceramide concentrations were assessed as potential predictors of change from baseline after 12 months by estimated glomerular filtration rate and left-ventricular mass index using pooled data from three randomized, placebo-controlled agalsidase alfa trials and open-label extens...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 May 2013
|
| In: |
Genetics in medicine
Year: 2013, Volume: 15, Issue: 12, Pages: 983-989 |
| ISSN: | 1530-0366 |
| DOI: | 10.1038/gim.2013.56 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/gim.2013.56 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/gim201356 
|
| Author Notes: | Raphael Schiffmann, Markus Ries, Derek Blankenship, Kathy Nicholls, Atul Mehta, Joe T. R. Clarke, Robert D. Steiner, Michael Beck, Bruce A. Barshop, William Rhead, Michael West, Rick Martin, David Amato, Nitin Nair and Pedro Huertas |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1761211722 | ||
| 003 | DE-627 | ||
| 005 | 20230426153112.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210624s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/gim.2013.56 |2 doi | |
| 035 | |a (DE-627)1761211722 | ||
| 035 | |a (DE-599)KXP1761211722 | ||
| 035 | |a (OCoLC)1341416938 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schiffmann, Raphael |e VerfasserIn |0 (DE-588)111475126X |0 (DE-627)869019376 |0 (DE-576)477474578 |4 aut | |
| 245 | 1 | 0 | |a Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa |c Raphael Schiffmann, Markus Ries, Derek Blankenship, Kathy Nicholls, Atul Mehta, Joe T. R. Clarke, Robert D. Steiner, Michael Beck, Bruce A. Barshop, William Rhead, Michael West, Rick Martin, David Amato, Nitin Nair and Pedro Huertas |
| 246 | 3 | 0 | |a one |
| 264 | 1 | |c 16 May 2013 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.06.2021 | ||
| 520 | |a Purpose: Globotriaosylceramide concentrations were assessed as potential predictors of change from baseline after 12 months by estimated glomerular filtration rate and left-ventricular mass index using pooled data from three randomized, placebo-controlled agalsidase alfa trials and open-label extensions of patients with Fabry disease. Methods: Males (aged 18 years or older) with Fabry disease received agalsidase alfa (0.2 mg/kg every other week for 12 months). A backward-elimination approach evaluated potential predictors (baseline estimated glomerular filtration rate and left-ventricular mass index; age at first dose; baseline and change from baseline at 12 months of globotriaosylceramide (urine, plasma); urine protein excretion; and systolic and diastolic blood pressure). Subgroups included patients randomized to placebo or agalsidase alfa (double-blind phase), then to agalsidase alfa (open-label extensions. Results: Baseline estimated glomerular filtration rate, age at first dose, baseline urine globotriaosylceramide excretion, and baseline and change from baseline urine protein excretion significantly predicted change from baseline estimated glomerular filtration rate in the analysis population (N = 73; all P<0.05), although not in all subgroups. Change from baseline urine and plasma globotriaosylceramide (baseline and change from baseline) concentrations did not predict change from baseline estimated glomerular filtration rate. No predictors of left-ventricular mass index were significant. Conclusion: Changes in globotriaosylceramide concentrations do not appear to be useful biomarkers for prediction of Fabry disease–related changes in estimated glomerular filtration rate or left-ventricular mass index. | ||
| 700 | 1 | |a Ries, Markus |d 1971- |e VerfasserIn |0 (DE-588)136385338 |0 (DE-627)582068479 |0 (DE-576)300993358 |4 aut | |
| 700 | 1 | |a Blankenship, Derek |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicholls, Kathy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mehta, Atul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clarke, Joe T. R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Steiner, Robert D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beck, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barshop, Bruce A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rhead, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a West, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martin, Rick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Amato, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nair, Nitin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huertas, Pedro |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genetics in medicine |d Amsterdam : Elsevier, 1998 |g 15(2013), 12, Seite 983-989 |h Online-Ressource |w (DE-627)338073361 |w (DE-600)2063504-7 |w (DE-576)109132475 |x 1530-0366 |7 nnas |a Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa |
| 773 | 1 | 8 | |g volume:15 |g year:2013 |g number:12 |g pages:983-989 |g extent:7 |a Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa |
| 856 | 4 | 0 | |u https://doi.org/10.1038/gim.2013.56 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/gim201356 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210624 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 136385338 |a Ries, Markus |m 136385338:Ries, Markus |d 910000 |d 910500 |e 910000PR136385338 |e 910500PR136385338 |k 0/910000/ |k 1/910000/910500/ |p 2 | ||
| 999 | |a KXP-PPN1761211722 |e 3941117432 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 24.06.2021"],"recId":"1761211722","id":{"doi":["10.1038/gim.2013.56"],"eki":["1761211722"]},"title":[{"title_sort":"Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa","title":"Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa"}],"relHost":[{"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American College of Medical Genetics","role":"isb"}],"titleAlt":[{"title":"GIM"}],"pubHistory":["1.1998/99 -"],"recId":"338073361","disp":"Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfaGenetics in medicine","note":["Gesehen am 27.07.2023"],"title":[{"title":"Genetics in medicine","title_sort":"Genetics in medicine","subtitle":"official journal of the American College of Medical Genetics"}],"id":{"issn":["1530-0366"],"eki":["338073361"],"zdb":["2063504-7"]},"part":{"pages":"983-989","year":"2013","extent":"7","volume":"15","issue":"12","text":"15(2013), 12, Seite 983-989"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"dateIssuedDisp":"1998-","dateIssuedKey":"1998","publisherPlace":"Amsterdam ; London, UK ; Baltimore, Md.","publisher":"Elsevier ; Springer Nature ; Lippincott, Williams & Wilkins"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"name":{"displayForm":["Raphael Schiffmann, Markus Ries, Derek Blankenship, Kathy Nicholls, Atul Mehta, Joe T. R. Clarke, Robert D. Steiner, Michael Beck, Bruce A. Barshop, William Rhead, Michael West, Rick Martin, David Amato, Nitin Nair and Pedro Huertas"]},"person":[{"given":"Raphael","role":"aut","display":"Schiffmann, Raphael","roleDisplay":"VerfasserIn","family":"Schiffmann"},{"role":"aut","display":"Ries, Markus","given":"Markus","family":"Ries","roleDisplay":"VerfasserIn"},{"given":"Derek","display":"Blankenship, Derek","role":"aut","family":"Blankenship","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Nicholls","role":"aut","display":"Nicholls, Kathy","given":"Kathy"},{"role":"aut","display":"Mehta, Atul","given":"Atul","roleDisplay":"VerfasserIn","family":"Mehta"},{"given":"Joe T. R.","display":"Clarke, Joe T. R.","role":"aut","family":"Clarke","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Steiner","given":"Robert D.","role":"aut","display":"Steiner, Robert D."},{"roleDisplay":"VerfasserIn","family":"Beck","given":"Michael","role":"aut","display":"Beck, Michael"},{"given":"Bruce A.","display":"Barshop, Bruce A.","role":"aut","family":"Barshop","roleDisplay":"VerfasserIn"},{"display":"Rhead, William","role":"aut","given":"William","roleDisplay":"VerfasserIn","family":"Rhead"},{"given":"Michael","role":"aut","display":"West, Michael","family":"West","roleDisplay":"VerfasserIn"},{"given":"Rick","display":"Martin, Rick","role":"aut","roleDisplay":"VerfasserIn","family":"Martin"},{"family":"Amato","roleDisplay":"VerfasserIn","display":"Amato, David","role":"aut","given":"David"},{"roleDisplay":"VerfasserIn","family":"Nair","given":"Nitin","role":"aut","display":"Nair, Nitin"},{"family":"Huertas","roleDisplay":"VerfasserIn","role":"aut","display":"Huertas, Pedro","given":"Pedro"}],"physDesc":[{"extent":"7 S."}],"origin":[{"dateIssuedDisp":"16 May 2013","dateIssuedKey":"2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} | ||
| SRT | |a SCHIFFMANNCHANGESINP1620 | ||